Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.
作者信息
Padler-Karavani Vered, Varki Ajit
机构信息
Glycobiology Research and Training Center, Department of Medicine, University of California at San Diego, La Jolla, CA, USA.
出版信息
Xenotransplantation. 2011 Jan-Feb;18(1):1-5. doi: 10.1111/j.1399-3089.2011.00622.x.
Abstract
摘要
相似文献
1
Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.
Xenotransplantation. 2011 Jan-Feb;18(1):1-5. doi: 10.1111/j.1399-3089.2011.00622.x.
2
Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies.
Xenotransplantation. 2010 Nov-Dec;17(6):440-8. doi: 10.1111/j.1399-3089.2010.00610.x.
3
Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
PLoS One. 2018 Jun 18;13(6):e0197464. doi: 10.1371/journal.pone.0197464. eCollection 2018.
4
Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice.
J Immunol. 2010 Mar 15;184(6):3269-75. doi: 10.4049/jimmunol.0902857. Epub 2010 Feb 19.
5
Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 3;7(2). doi: 10.1212/NXI.0000000000000676. Print 2020 Mar.
6
Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States.
Front Immunol. 2020 Jul 23;11:1589. doi: 10.3389/fimmu.2020.01589. eCollection 2020.
7
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.
Nat Biotechnol. 2010 Aug;28(8):863-7. doi: 10.1038/nbt.1651. Epub 2010 Jul 25.
8
Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
Front Immunol. 2018 Dec 4;9:2885. doi: 10.3389/fimmu.2018.02885. eCollection 2018.
9
Are there specific antibodies against Neu5Gc epitopes in the blood of healthy individuals?
Glycobiology. 2020 May 19;30(6):395-406. doi: 10.1093/glycob/cwz107.
10
Immune disguise: the mechanisms of Neu5Gc inducing autoimmune and transplant rejection.
Genes Immun. 2022 Sep;23(6):175-182. doi: 10.1038/s41435-022-00182-8. Epub 2022 Sep 23.
引用本文的文献
1
Serological Assessment of Alpha Galactosidase, N-Glycolylneuraminic Acid, and Histopathological Observations in Xenograft Recipients.
Cureus. 2025 Aug 29;17(8):e91236. doi: 10.7759/cureus.91236. eCollection 2025 Aug.
2
2025: status of cardiac xenotransplantation including preclinical models.
Front Transplant. 2025 Apr 15;4:1568910. doi: 10.3389/frtra.2025.1568910. eCollection 2025.
3
Mutations Inactivating Biosynthesis of Dispensable Carbohydrate-Antigens Prevented Extinctions in Primate/Human Lineage Evolution.
J Mol Evol. 2025 Apr;93(2):212-228. doi: 10.1007/s00239-025-10243-x. Epub 2025 Mar 30.
4
Progress in Porcine Kidney Transplantation to Non-Human Primates.
Transpl Int. 2025 Feb 14;38:14003. doi: 10.3389/ti.2025.14003. eCollection 2025.
5
Generation and characterization of genetically modified pigs with GGTA1/β4GalNT2/CMAH knockout and human CD55/CD47 expression for xenotransfusion studies.
Sci Rep. 2024 Dec 2;14(1):29870. doi: 10.1038/s41598-024-81730-2.
6
A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid 'xenoautoantigen' Neu5Gc in humans and the need for a standardised approach to quantification.
Front Mol Biosci. 2024 Apr 26;11:1390711. doi: 10.3389/fmolb.2024.1390711. eCollection 2024.
7
Progress in islet xenotransplantation: Immunologic barriers, advances in gene editing, and tolerance induction strategies for xenogeneic islets in pig-to-primate transplantation.
Front Transplant. 2022;1. doi: 10.3389/frtra.2022.989811. Epub 2022 Oct 20.
8
Current Status of Cardiac Xenotransplantation: Report of a Workshop of the German Heart Transplant Centers, Martinsried, March 3, 2023.
Thorac Cardiovasc Surg. 2024 Jun;72(4):273-284. doi: 10.1055/a-2235-8854. Epub 2023 Dec 28.
9
Preventative and therapeutic potential of animal milk components against COVID-19: A comprehensive review.
Food Sci Nutr. 2023 Mar 23;11(6):2547-2579. doi: 10.1002/fsn3.3314. eCollection 2023 Jun.
10
Cells and Materials for Cardiac Repair and Regeneration.
J Clin Med. 2023 May 10;12(10):3398. doi: 10.3390/jcm12103398.
本文引用的文献
1
Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies.
Xenotransplantation. 2010 Nov-Dec;17(6):440-8. doi: 10.1111/j.1399-3089.2010.00610.x.
2
Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
PLoS One. 2010 Nov 23;5(11):e14099. doi: 10.1371/journal.pone.0014099.
3
The sialome--far more than the sum of its parts.
OMICS. 2010 Aug;14(4):455-64. doi: 10.1089/omi.2009.0148.
4
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.
Nat Biotechnol. 2010 Aug;28(8):863-7. doi: 10.1038/nbt.1651. Epub 2010 Jul 25.
5
Investigation of potential carbohydrate antigen targets for human and baboon antibodies.
Xenotransplantation. 2010 May-Jun;17(3):197-206. doi: 10.1111/j.1399-3089.2010.00579.x.
6
Colloquium paper: uniquely human evolution of sialic acid genetics and biology.
Proc Natl Acad Sci U S A. 2010 May 11;107 Suppl 2(Suppl 2):8939-46. doi: 10.1073/pnas.0914634107. Epub 2010 May 5.
7
Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice.
J Immunol. 2010 Mar 15;184(6):3269-75. doi: 10.4049/jimmunol.0902857. Epub 2010 Feb 19.
8
Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies.
Xenotransplantation. 2010 Jan-Feb;17(1):48-60. doi: 10.1111/j.1399-3089.2009.00564.x.
9
Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms.
Stem Cells. 2010 Feb;28(2):258-67. doi: 10.1002/stem.250.
10
Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.
Tissue Eng Part A. 2010 Apr;16(4):1143-55. doi: 10.1089/ten.TEA.2009.0386.
Zotero 插件